EMILY STEPHENSON: Open Payments
NPI 1215677943 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,376 in 92 payments from 16 companies in 2025. Trend: 2023 $752 · 2024 $816 · 2025 $1,376
Food & beverage: $1,333Education: $42
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $256 |
| Vanda Pharmaceuticals Inc. | 18 | $228 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $148 |
| Axsome Therapeutics, Inc. | 8 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
| Lundbeck LLC | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
Products named: VRAYLAR, FANAPT, CAPLYTA, Auvelity, REXULTI, TRINTELLIX, INGREZZA, AUSTEDO XR.
Industry payments across IN — which companies pay providers there.
